Efficacy and Safety Evaluating IPI-504 With Trastuzumab in Patients With Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

This study is currently recruiting participants.

Study NCT00817362 Information provided by Infinity Pharmaceuticals

First Received: January 5, 2009 Last Updated: November 5, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2011
Estimated Primary Completion Date:	September 2011 (Final data collection date for primary outcome measure)